1.         Ochom E, Robsky KO, Gupta AJ, Tamale A, Kungu J, Turimumahoro P, Nakasendwa S, Rwego IB, Muttamba W, Joloba M et al: Geographic distribution and predictors of diagnostic delays among possible TB patients in Uganda. Public health action 2023, 13(3):70-76.

2.         Musisi E, Wyness A, Eldirdiri S, Dombay E, Mtafya B, Ntinginya NE, Heinrich N, Kibiki GS, Hoelscher M, Boeree M et al: Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials. Lancet Microbe 2023.

3.         Katamba A, Ssengooba W, Sserubiri J, Semugenze D, Kasule GW, Nyombi A, Byaruhanga R, Turyahabwe S, Joloba ML: Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda. PLoS One 2023, 18(8):e0284545.

4.         Garcia-Basteiro AL, Cobelens F, Ssengooba W, Theron G: Lots of considerations when evaluating the FujiLAM assay. Lancet Glob Health 2023, 11(4):e501.

5.         Chabala C, Turkova A, Kapasa M, LeBeau K, Tembo CH, Zimba K, Weisner L, Zyambo K, Choo L, Chungu C et al: Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV. Pediatr Infect Dis J 2023, 42(10):899-904.

6.         Turkova A, Wills GH, Wobudeya E, Chabala C, Palmer M, Kinikar A, Hissar S, Choo L, Musoke P, Mulenga V et al: Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children. N Engl J Med 2022, 386(10):911-922.

7.         Smith-Jeffcoat SE, Eisenach KD, Joloba M, Ssengooba W, Namaganda C, Nsereko M, Okware B, Cavanaugh JS, Cegielski JP: Quantification of multidrug-resistant M. tuberculosis bacilli in sputum during the first 8 weeks of treatment. Int J Tuberc Lung Dis 2022, 26(11):1058-1064.

8.         Oloya B, Namukobe J, Ssengooba W, Afayoa M, Byamukama R: Phytochemical screening, antimycobacterial activity and acute toxicity of crude extracts of selected medicinal plant species used locally in the treatment of tuberculosis in Uganda. Trop Med Health 2022, 50(1):16.

9.         Nakku-Joloba E, Mboowa G, Ssengooba W, Kiyimba A, Kigozi E, Baluku H, Alinaitwe L, Nyote R, Kabahita JM, Mutumba P et al: Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda. Afr Health Sci 2022, 22(3):62-71.

10.       Nakiyingi L, Baluku JB, Ssengooba W, Namiiro SM, Buyego P, Kimuli I, Adakun S: Recurrent pneumothorax in a human immunodeficiency virus-positive patient with multidrug-resistant tuberculosis: a rare case of bronchopleural fistula: a case report. J Med Case Rep 2022, 16(1):214.

11.       Musisi E, Sessolo A, Kaswabuli S, Zawedde J, Byanyima P, Kasinga S, Sanyu I, Uwimaana E, Walimbwa S, Olore J et al: High Mycobacterium tuberculosis Bacillary Loads Detected by Tuberculosis Molecular Bacterial Load Assay in Patient Stool: a Potential Alternative for Nonsputum Diagnosis and Treatment Response Monitoring of Tuberculosis. Microbiology spectrum 2022:e0210021.

12.       Musiime V, Kiggwe A, Beinomugisha J, Kakooza L, Thembo-Mwesige J, Nkinzi S, Naguti E, Atuhaire L, Segawa I, Ssengooba W et al: Strategies to Reduce Mortality Among Children Living With HIV and Children Exposed to HIV but Are Uninfected, Admitted With Severe Acute Malnutrition at Mulago Hospital, Uganda (REDMOTHIV): A Mixed Methods Study. Front Pediatr 2022, 10:880355.

13.       Mujuni D, Kasemire DL, Ibanda I, Kabugo J, Nsawotebba A, Phelan JE, Majwala RK, Tugumisirize D, Nyombi A, Orena B et al: Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review. BMC Infect Dis 2022, 22(1):363.

14.       Cook A, Sharland M, Yau Y, Group P, Bielicki J, Pedi BSIG: Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA). Expert Rev Anti Infect Ther 2022, 20(3):445-456.

15.       Baluku JB, Nabwana M, Nalunjogi J, Muttamba W, Mubangizi I, Nakiyingi L, Ssengooba W, Olum R, Bongomin F, Andia-Biraro I et al: Cardiovascular risk factors among people with drug-resistant tuberculosis in Uganda. BMC Cardiovasc Disord 2022, 22(1):464.

16.       Yassine E, Galiwango R, Ssengooba W, Ashaba F, Joloba ML, Zalwango S, Whalen CC, Quinn F: Assessing a transmission network of Mycobacterium tuberculosis in an African city using single nucleotide polymorphism threshold analysis. Microbiologyopen 2021, 10(3):e1211.

17.       Ssengooba W, Komakech K, Namiiro S, Byabajungu H, Nalunjogi J, Katagira W, Kimuli I, Joloba ML, Adakun S, Nakiyingi L et al: Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda. Journal of clinical tuberculosis and other mycobacterial diseases 2021, 25:100286.

18.       Ssengooba W, de Dieu Iragena J, Komakech K, Okello I, Nalunjogi J, Katagira W, Kimuli I, Adakun S, Joloba ML, Torrea G et al: Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda. Open Forum Infect Dis 2021, 8(6):ofab173.

19.       Ocheretina O, Brandao AP, Pang Y, Rodrigues C, Banu S, Ssengooba W, Dolinger DL, Salfinger M, Ngabonziza JCS, Koser CU: Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert((R)) MTB/RIF. Int J Tuberc Lung Dis 2021, 25(11):881-885.

20.       Nsawotebba A, Ibanda I, Ssewanyana I, Ogwok P, Ocen F, Okiira C, Kagirita A, Mujuni D, Tugumisirize D, Kabugo J et al: Effectiveness of thermal screening in detection of COVID-19 among truck drivers at Mutukula Land Point of Entry, Uganda. PLoS One 2021, 16(5):e0251150.

21.       Namugenyi J, Musaazi J, Katamba A, Kalyango J, Sendaula E, Kambugu A, Fehr J, Castelnouvo B, Manabe YC, Ssengooba W et al: Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study. BMC Infect Dis 2021, 21(1):513.

22.       Nakiyingi L, Bwanika JM, Ssengooba W, Mubiru F, Nakanjako D, Joloba ML, Mayanja-Kizza H, Manabe YC: Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting. BMC Infect Dis 2021, 21(1):63.

23.       Kateete DP, Mbabazi MM, Nakazzi F, Katabazi FA, Kigozi E, Ssengooba W, Nakiyingi L, Namiiro S, Okwera A, Joloba ML et al: Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy. Scientific reports 2021, 11(1):24486.

24.       Bogere N, Bongomin F, Katende A, Ssebambulidde K, Ssengooba W, Ssenfuka H, Kigozi E, Biraro S, Kateete DP, Andia-Biraro I: Performance and Cost-Effectiveness of a Pooled-Testing Strategy for SARS-CoV-2 Using Real-Time Polymerase Chain Reaction in Uganda. Int J Infect Dis 2021.

25.       Achan B, Asiimwe BB, Joloba ML, Gumusboga M, Ssengooba W, Bwanga F: The simple direct slide method is comparable to indirect Lowenstein Jensen proportion culture for detecting rifampicin resistant tuberculosis. J Med Microbiol 2021.

26.       Ssengooba W, Iragena JD, Nakiyingi L, Mujumbi S, Wobudeya E, Mboizi R, Boulware D, Meya DB, Choo L, Crook AM et al: Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial. J Clin Microbiol 2020, 58(9).

27.       Ngabonziza JCS, Loiseau C, Marceau M, Jouet A, Menardo F, Tzfadia O, Antoine R, Niyigena EB, Mulders W, Fissette K et al: A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region. Nat Commun 2020, 11(1):2917.

28.       Naluyange R, Mboowa G, Komakech K, Semugenze D, Kateete DP, Ssengooba W: High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda. PLoS One 2020, 15(5):e0232543.

29.       Torrea G, Ng KCS, Van Deun A, Andre E, Kaisergruber J, Ssengooba W, Desmaretz C, Gabriels S, Driesen M, Diels M et al: Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance. Scientific reports 2019, 9(1):11826.

30.       Najjingo I, Muttamba W, Kirenga BJ, Nalunjogi J, Bakesiima R, Olweny F, Lusiba P, Katamba A, Joloba M, Ssengooba W: Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study. PLoS One 2019, 14(5):e0216901.

31.       Muttamba W, Ssengooba W, Kirenga B, Sekibira R, Walusimbi S, Katamba A, Joloba M: Health seeking behavior among individuals presenting with chronic cough at referral hospitals in Uganda; Missed opportunity for early tuberculosis diagnosis. PLoS One 2019, 14(6):e0217900.

32.       Muttamba W, Kirenga B, Ssengooba W, Sekibira R, Katamba A, Joloba ML: Prevalence of Tuberculosis Risk Factors among Bacteriologically Negative and Bacteriologically Confirmed Tuberculosis Patients from Five Regional Referral Hospitals in Uganda. Am J Trop Med Hyg 2019, 100(2):386-391.

33.       Chin JH, Ssengooba W, Grossman S, Pellinen J, Wadda V: Xpert MTB/RIF Ultra: Optimal procedures for the detection of Mycobacterium tuberculosis in cerebrospinal fluid. Journal of clinical tuberculosis and other mycobacterial diseases 2019, 14:16-18.

34.       Chin JH, Musubire AK, Morgan N, Pellinen J, Grossman S, Bhatt JM, Wadda V, Ssengooba W: Xpert MTB/RIF Ultra for Detection of Mycobacterium tuberculosis in Cerebrospinal Fluid. J Clin Microbiol 2019, 57(6).

35.       Ssengooba W, Nakayita G, Namaganda CC, Joloba ML: Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing. PLoS One 2018, 13(6):e0199638.

36.       Nakiyingi L, Nakanwagi P, Briggs J, Agaba T, Mubiru F, Mugenyi M, Ssengooba W, Joloba ML, Manabe YC: Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda. BMC Infect Dis 2018, 18(1):87.

37.       Muttamba W, Ssengooba W, Sekibira R, Kirenga B, Katamba A, Joloba M: Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out. PLoS One 2018, 13(3):e0194741.

38.       Ssengooba W, Lukoye D, Meehan CJ, Kateete DP, Joloba ML, de Jong BC, Cobelens FG, van Leth F: Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda. Int J Tuberc Lung Dis 2017, 21(5):531-536.

39.       Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE, 3rd, Brand J, Consortium TBGG, Chapman SB, Cho SN et al: Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nat Genet 2017, 49(3):395-402.

40.       Stucki D, Brites D, Jeljeli L, Coscolla M, Liu Q, Trauner A, Fenner L, Rutaihwa L, Borrell S, Luo T et al: Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages. Nat Genet 2016, 48(12):1535-1543.

41.       Ssengooba W, Respeito D, Mambuque E, Blanco S, Bulo H, Mandomando I, de Jong BC, Cobelens FG, Garcia-Basteiro AL: Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis? PLoS One 2016, 11(9):e0162833.

42.       Ssengooba W, Meehan CJ, Lukoye D, Kasule GW, Musisi K, Joloba ML, Cobelens FG, de Jong BC: Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda. Infect Genet Evol 2016, 40:8-16.

43.       Ssengooba W, de Jong BC, Joloba ML, Cobelens FG, Meehan CJ: Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients. BMC Infect Dis 2016, 16(1):1-7.

44.       Ssengooba W, de Jong BC, Joloba ML, Cobelens FG, Meehan CJ: Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients. BMC Infect Dis 2016, 16:371.

45.       Ngabonziza JC, Ssengooba W, Mutua F, Torrea G, Dushime A, Gasana M, Andre E, Uwamungu S, Nyaruhirira AU, Mwaengo D et al: Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda. BMC Infect Dis 2016, 16(1):660.

46.       Ssengooba W, Gelderbloem SJ, Mboowa G, Wajja A, Namaganda C, Musoke P, Mayanja-Kizza H, Joloba ML: Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda. Health Res Policy Syst 2015, 13:4.

47.       Ssengooba W, Cobelens FG, Nakiyingi L, Mboowa G, Armstrong DT, Manabe YC, Joloba ML, de Jong BC: High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals. PLoS One 2015, 10(7):e0132581.

48.       Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ et al: Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. BMC Infect Dis 2015, 15:62.

49.       Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE et al: Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology. PLoS One 2015, 10(7):e0133756.

50.       Mumpe-Mwanja D, Verver S, Yeka A, Etwom A, Waako J, Ssengooba W, Matovu JK, Wanyenze RK, Musoke P, Mayanja-Kizza H: Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda. Afr Health Sci 2015, 15(3):851-860.

51.       Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FG, Joloba M, Gomez GB: Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health 2015, 15:291.

52.       Kirenga BJ, Ssengooba W, Muwonge C, Nakiyingi L, Kyaligonza S, Kasozi S, Mugabe F, Boeree M, Joloba M, Okwera A: Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control. BMC Public Health 2015, 15:13.

53.       Dharan NJ, Amisano D, Mboowa G, Ssengooba W, Blakemore R, Kubiak RW, Armstrong DT, Jones M, Manabe YC, Joloba ML et al: Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation. J Clin Microbiol 2015, 53(4):1258-1263.

54.       Ssengooba W, Nakiyingi L, Armstrong DT, Cobelens FG, Alland D, Manabe YC, Dorman SE, Ellner JJ, Joloba ML: Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda. PLoS One 2014, 9(9):e107595.

55.       Shah M, Ssengooba W, Armstrong D, Nakiyingi L, Holshouser M, Ellner JJ, Joloba M, Manabe YC, Dorman SE: Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. AIDS 2014, 28(9):1307-1314.

56.       Muwonge A, Malama S, Bronsvoort BM, Biffa D, Ssengooba W, Skjerve E: A comparison of tools used for tuberculosis diagnosis in resource-limited settings: a case study at Mubende referral hospital, Uganda. PLoS One 2014, 9(6):e100720.

57.       Mboowa G, Namaganda C, Ssengooba W: Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert(R) MTB/RIF in Kampala, Uganda: a retrospective study. BMC Infect Dis 2014, 14:481.

58.       Lusiba JK, Nakiyingi L, Kirenga BJ, Kiragga A, Lukande R, Nsereko M, Ssengooba W, Katamba A, Worodria W, Joloba ML et al: Evaluation of Cepheid’s Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting. PLoS One 2014, 9(7):e102702.

59.       Lee J, Armstrong DT, Ssengooba W, Park JA, Yu Y, Mumbowa F, Namaganda C, Mboowa G, Nakayita G, Armakovitch S et al: Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother 2014, 58(1):11-18.

60.       Jones-Lopez E, Manabe YC, Palaci M, Kayiza C, Armstrong D, Nakiyingi L, Ssengooba W, Gaeddert M, Kubiak R, Almeida Junior P et al: Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2014, 52(7):2513-2520.

61.       Waako J, Verver S, Wajja A, Ssengooba W, Joloba ML, Colebunders R, Musoke P, Mayanja-Kizza H: Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda. BMC Infect Dis 2013, 13:349.

62.       Shah M, Dowdy D, Joloba M, Ssengooba W, Manabe YC, Ellner J, Dorman SE: Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda. AIDS 2013, 27(18):2883-2892.

63.       Sekadde MP, Wobudeya E, Joloba ML, Ssengooba W, Kisembo H, Bakeera-Kitaka S, Musoke P: Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study. BMC Infect Dis 2013, 13:133.

64.       Nantongo JM, Wobudeya E, Mupere E, Joloba M, Ssengooba W, Kisembo HN, Lubega IR, Musoke PM: High incidence of pulmonary tuberculosis in children admitted with severe pneumonia in Uganda. BMC Pediatr 2013, 13:16.

65.       Muwonge A, Malama S, Johansen TB, Kankya C, Biffa D, Ssengooba W, Godfroid J, Djonne B, Skjerve E: Molecular epidemiology, drug susceptibility and economic aspects of tuberculosis in Mubende district, Uganda. PLoS One 2013, 8(5):e64745.

66.       Muwonge A, Kankya C, Olea-Popelka F, Biffa D, Ssengooba W, Berit D, Skjerve E, Johansen TB: Molecular investigation of multiple strain infections in patients with tuberculosis in Mubende district, Uganda. Infect Genet Evol 2013, 17:16-22.

67.       Asiimwe BB, Bagyenzi GB, Ssengooba W, Mumbowa F, Mboowa G, Wajja A, Mayanja-Kiiza H, Musoke PM, Wobudeya E, Kallenius G et al: Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda. BMC Infect Dis 2013, 13:88.

68.       Ssengooba W, Kiwanuka N, Kateete DP, Katamba A, Joloba ML: Incremental yield of serial sputum cultures for diagnosis of tuberculosis among HIV infected smear negative pulmonary TB suspects in Kampala, Uganda. PLoS One 2012, 7(5):e37650.

69.       Ssengooba W, Kateete DP, Wajja A, Bugumirwa E, Mboowa G, Namaganda C, Nakayita G, Nassolo M, Mumbowa F, Asiimwe BB et al: An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda. Tuberc Res Treat 2012, 2012:970203.